首页> 外国专利> odt; odt composition; method for preparing a multiparticulate odt tablet, method for treating or preventing postoperative nausea and vomiting or post-discharge nausea and vomiting for up to 24 hours after dosing, method for treating pu preventing nausea for up to 24 hours after dosing and Method for treating or preventing nausea and vomiting associated with radiotherapy in patients receiving either full body irradiation, single high dose to the abdomen, or daily fractions to the abdomen for up to 24 hours after dosing.

odt; odt composition; method for preparing a multiparticulate odt tablet, method for treating or preventing postoperative nausea and vomiting or post-discharge nausea and vomiting for up to 24 hours after dosing, method for treating pu preventing nausea for up to 24 hours after dosing and Method for treating or preventing nausea and vomiting associated with radiotherapy in patients receiving either full body irradiation, single high dose to the abdomen, or daily fractions to the abdomen for up to 24 hours after dosing.

机译:odt; odt组成;给药后最多24小时的多颗粒odt片剂的制备方法,术后恶心,呕吐或出院后恶心和呕吐的治疗或预防方法,给药后长达24小时的pu预防恶心的治疗方法和治疗方法防止在接受全身照射,对腹部单次高剂量或每天服用少量腹膜的患者接受放射治疗后与放疗相关的恶心和呕吐长达24小时。

摘要

This invention is related to a pharmaceutical composition in the patient-friendly orally disintegrating tablet form comprising a weakly basic, selective serotonin 5-HT3 blocking agent for the prevention of nausea and/or vomiting for up to 24 hrs postdosing in cancer patients prior to undergoing moderately emetogenic chemotherapy or partial or whole body radiotherapy or in subjects at moderate to high risk of postoperative or postdischarge nausea and/or vomiting prior to inpatient or outpatient ambulatory surgery. The unit dosage form comprising a multitude of immediate-release drug particles providing dissolution profiles similar to that of reference drug product, and one or more timed, pulsatile-release bead populations, comprising at least one organic acid, which solubilizes said weakly basic selective serotonin 5-HT3 blocking agent prior to releasing it into the hostile intestinal environment, wherein the blocking agent is practically insoluble, is capable of delivering said antiemetic agent in patients in need thereof in a sustained-released fashion to be suitable for a once-daily dosing regimen.
机译:本发明涉及对患者友好的口腔崩解片剂形式的药物组合物,其包含弱碱性的选择性5-羟色胺5-HT 3阻断剂,用于预防恶性和/或呕吐在癌症患者中给药后长达24小时之前中度致癌化学疗法或部分或全身放疗,或在住院或门诊非卧床手术前有中等或高风险的术后或出院后恶心和/或呕吐的受试者。单位剂型包含提供与参考药物产品相似的溶出曲线的大量速释药物颗粒,以及一种或多种定时的脉动释放珠群,其包含至少一种有机酸,其可溶解所述弱碱性选择性5-羟色胺5-HT3阻断剂在释放到敌对肠环境中之前,其中的阻断剂实际上是不溶的,能够以需要持续释放的方式向有需要的患者递送所述止吐药,以适合于每日一次给药养生。

著录项

  • 公开/公告号BR112012013011A2

    专利类型

  • 公开/公告日2015-09-08

    原文格式PDF

  • 申请/专利权人 APTALIS PHARMATECH INC.;

    申请/专利号BR20121113011

  • 发明设计人 GOPI M. VENKATESH;

    申请日2010-11-23

  • 分类号A01N43/50;

  • 国家 BR

  • 入库时间 2022-08-21 15:16:24

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号